Investigating how a specific enzyme affects wound healing and inflammation
The role and mechanistic regulation of cPLA2alpha in eicosanoid biosynthesis and wound healing
This study is looking at how a specific enzyme helps with healing wounds and managing inflammation, using a special mouse model to see how changing this enzyme affects the healing process, which could lead to better treatments for conditions like pressure ulcers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10749051 on NIH RePORTER |
What this research studies
This research explores the role of a specific enzyme, cPLA2α, in the production of eicosanoids, which are important for wound healing and inflammation. By using advanced lipidomic technology, the study examines how this enzyme interacts with certain lipids during the healing process. Researchers have created a special mouse model to observe the effects of manipulating this enzyme on wound healing, particularly focusing on how it influences the balance of inflammatory and anti-inflammatory substances. The findings aim to provide insights into improving healing for conditions like pressure ulcers.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from chronic wounds, such as pressure ulcers or other types of non-healing injuries.
Not a fit: Patients with acute wounds or those not experiencing issues related to inflammation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance wound healing and reduce inflammation for patients with chronic wounds.
How similar studies have performed: Previous research has shown promising results in manipulating eicosanoid pathways for improving wound healing, suggesting that this approach could be effective.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Chalfant, Charles E. — University of Virginia
- Study coordinator: Chalfant, Charles E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.